List of Vion Pharmaceuticals, Inc. patents

List of Vion Pharmaceuticals, Inc. patents

List of Heat Biologics patents

List of CRISPR Therapeutics patents

List of Ambrx patents

Companies in the Fabless manufacturing industry

List of companies in Vela Partners's investment portfolio

Patents where

Current Assignee

Name

is

‌

Vion Pharmaceuticals, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 6962696 Compositions and methods for tumor-targeted delivery of effector molecules	Patent 6962696 was granted and assigned to Vion Pharmaceuticals, Inc. on November, 2005 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	6962696	November 8, 2005
	‌ US Patent 7452531 Compositions and methods for tumor-targeted delivery of effector molecules	Patent 7452531 was granted and assigned to Vion Pharmaceuticals, Inc. on November, 2008 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	7452531	November 18, 2008
	‌ US Patent 7605137 Combination therapy comprising cloretazine	Patent 7605137 was granted and assigned to Vion Pharmaceuticals, Inc. on October, 2009 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	7605137	October 20, 2009
	‌ US Patent 6863894 Genetically modified tumor-targeted bacteria with reduced virulence	Patent 6863894 was granted and assigned to Vion Pharmaceuticals, Inc. on March, 2005 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	6863894	March 8, 2005
	‌ US Patent 7273714 Alkylguanyltransferase assays	Patent 7273714 was granted and assigned to Vion Pharmaceuticals, Inc. on September, 2007 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	7273714	September 25, 2007
	‌ US Patent 6923972 Methods for use of genetically modified tumor-targeted bacteria with reduced virulence	Patent 6923972 was granted and assigned to Vion Pharmaceuticals, Inc. on August, 2005 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	6923972	August 2, 2005
	‌ US Patent 7514089 Genetically modified tumor-targeted bacteria with reduced virulence	Patent 7514089 was granted and assigned to Vion Pharmaceuticals, Inc. on April, 2009 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	7514089	April 7, 2009
	‌ US Patent 7405317 Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents	Patent 7405317 was granted and assigned to Vion Pharmaceuticals, Inc. on July, 2008 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	7405317	July 29, 2008
	‌ US Patent 6911460 Antiviral agents and methods of treating viral infections	Patent 6911460 was granted and assigned to Vion Pharmaceuticals, Inc. on June, 2005 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	6911460	June 28, 2005
	‌ US Patent 6855695 Water-soluble SHPs as novel alkylating agents	Patent 6855695 was granted and assigned to Vion Pharmaceuticals, Inc. on February, 2005 by the United States Patent and Trademark Office.		‌ Vion Pharmaceuticals, Inc.		United States Patent and Trademark Office	6855695	February 15, 2005

10 results

0 selected

10 results

0 selected